Article
Cancer stem cell-mediated therapeutic resistance in hepatocellular carcinoma
2022-01-01
Abstract excerpt
Hepatocellular carcinoma (HCC) is a highly heterogeneous malignancy. In the clinic, therapeutic resistance is largely attributed to tumor heterogeneity. Growing evidence indicates that cancer stem cells (CSCs) are the major source of tumor heterogeneity. Hence, uncovering the resistance mechanisms associated with CSC properties is essential for developing effective therapeutics. CSCs resemble embryonic stem cells....
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- af8468d8-aa4b-57df-a3f8-4dcc5740621a
- DOI
- 10.20517/2394-5079.2022.43
